Olah, 2002 - Google Patents
The development and implementation of bioanalytical methods using LC-MS to support ADME studies in early drug discovery and candidate selectionOlah, 2002
View PDF- Document ID
- 3889329816287661415
- Author
- Olah T
- Publication year
- Publication venue
- Pharmacokinetic Challenges in Drug Discovery
External Links
Snippet
The dramatic improvement in bioanalytical method development and application within the pharmaceutical industry began in the early 1990s with the commercial availability of liquid chromatography-mass spectrometry (LC-MS) systems. As the power of this type of detection …
- 238000011161 development 0 title abstract description 45
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00178—Special arrangements of analysers
- G01N2035/00326—Analysers with modular structure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
- G01N30/94—Development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10739321B2 (en) | Automated system for sample preparation and analysis | |
Nalbantoglu | Metabolomics: basic principles and strategies | |
Clarke | Mass spectrometry in the clinical laboratory: Determining the need and avoiding pitfalls | |
Watt et al. | Approaches to higher-throughput pharmacokinetics (HTPK) in drug discovery | |
US20070083337A1 (en) | Method of using data binning in the analysis of chromatography/spectrometry data | |
Shipkova et al. | Liquid chromatography tandem mass spectrometry for therapeutic drug monitoring of immunosuppressive drugs: achievements, lessons and open issues | |
AU2015261711B2 (en) | Automated system for sample preparation and analysis | |
JP2003532117A (en) | Proteomics analysis by parallel mass spectrometry | |
Bateman et al. | Reduction of animal usage by serial bleeding of mice for pharmacokinetic studies: application of robotic sample preparation and fast liquid chromatography–mass spectrometry | |
Xu et al. | Rapid LC/MS/MS method development for drug discovery | |
Leuthold et al. | Simultaneous selected reaction monitoring, MS/MS and MS3 quantitation for the analysis of pharmaceutical compounds in human plasma using chip‐based infusion | |
Biddlecombe et al. | A clinical trial on a plate? The potential of 384‐well format solid phase extraction for high‐throughput bioanalysis using liquid chromatography/tandem mass spectrometry | |
Bakhtiar et al. | High-throughput mass spectrometric analysis of xenobiotics in biological fluids | |
Olah | The development and implementation of bioanalytical methods using LC-MS to support ADME studies in early drug discovery and candidate selection | |
Unger | Using mass spectrometry to determine ADME properties in drug discovery | |
US20230128672A1 (en) | Methods and Systems for Measuring Progesterone Metabolites | |
Seger et al. | Some important aspects of implementing tandem mass spectrometry | |
CN101165482A (en) | Standard reagent kit for mass spectrometry clinical diagnosis and the method | |
Kumari et al. | Exploring the Utilization and Application of Mass Spectrophotometry across Various Fields within Clinical Laboratory Science | |
Hamelin et al. | Quantitation of tetramethylene disulfotetramine in human urine using isotope dilution gas chromatography mass spectrometry (GC/MS and GC/MS/MS) | |
Korfmacher | 7 Strategies and Techniques for Higher Throughput | |
Lee | Spectroscopic methods of analysis—mass spectrometry | |
Fernández‐Metzler et al. | Application of technological advances in biotransformation studies | |
Mendez et al. | A short reflection addressed to the analysts about the relationship between mass spectrometry and sample preparation | |
Tsarbopoulos et al. | Structural analysis of glycoproteins by electrospray ionization mass spectrometry |